The role of progesterone (P4) in the regulation of the local (uterine) and systemic innate immune system, myometrial expression of connexin 43 (Cx-43) and cyclooxygenase 2 (COX-2), and the onset of parturition was examined in (i) naïve mice delivering at term; (ii) E16 mice treated with RU486 (P4-antagonist) to induce preterm parturition; and (iii) in mice treated with P4 to prevent term parturition. In naïve mice, myometrial neutrophil and monocyte numbers peaked at E18 and declined with the onset of parturition. In contrast, circulating monocytes did not change and although neutrophils were increased with pregnancy, they did not change across gestation. The myometrial mRNA and protein levels of most chemokines/cytokines, Cx-43, and COX-2 increased with, but not before, parturition. With RU486-induced parturition, myometrial and systemic neutrophil numbers increased before and myometrial monocyte numbers increased with parturition only. Myometrial chemokine/cytokine mRNA abundance increased with parturition, but protein levels peaked earlier at between 4.5 and 9 h post-RU486. Cx-43, but not COX-2, mRNA expression and protein levels increased prior to the onset of parturition. In mice treated with P4, the gestation-linked increase in myometrial monocyte, but not neutrophil, numbers was prevented, and expression of Cx-43 and COX-2 was reduced. On E20 of P4 supplementation, myometrial chemokine/cytokine and leukocyte numbers, but not Cx-43 and COX-2 expression, increased. These data show that during pregnancy P4 controls myometrial monocyte infiltration, cytokine and prolabor factor synthesis via mRNAdependent and independent mechanisms and, with prolonged P4 supplementation, P4 action is repressed resulting in increased myometrial inflammation. Mouse parturition, progesterone and immune system, 2018, Vol. 98, No. 3 
Introduction
The uterus is a key site of immune activity during human pregnancy and labor [1] [2] [3] . As pregnancy advances, the myometrium is invaded by increasing numbers of monocytes, dendritic cells, and neutrophils. These cells, in addition to their immune roles, may modulate pregnancy outcome by influencing myometrial function [4] .
Murine monocytes exist as, at least, two phenotypically and functionally distinct subsets; these are distinguished by levels of the cell surface marker Ly-6C, which is higher on monocytes in the bone marrow and immediately after they have migrated into the circulation. Sunderkötter et al showed that the Ly-6C HI bone marrowderived blood monocyte matures over the course of 3 days, with Ly-6C expression declining until the mature monocyte becomes part of the Ly-6C LO monocyte subset [5] [6] [7] . The Ly-6C HI monocyte subset is preferentially recruited to sites of active inflammation [5, 8, 9] by the production of chemokine ligand 2 (CCL2), which is also known as monocyte chemoattractant protein 1, and which stimulates Ly-6C HI monocyte egress from the bone marrow and extravasation into tissue [8] . Tagliani et al demonstrated that the uterus actively recruits the Ly-6C HI monocyte subset rather than the Ly-6C LO subset during gestational development [10] . Nevertheless, the timing and pattern of recruitment of monocyte subsets into the uterus in late gestation and prior to labor has not yet been investigated. The uterine macrophage population has been reported to increase in density during pregnancy until labor [11] [12] [13] , suggesting that macrophages may play a key role in parturition [2] . Recent evidence indicates that blood monocyte trafficking to the uterus is central to expansion of the macrophage population during pregnancy [13] . CCL2 production may be influenced by progesterone (P4) and uterine stretch [14] [15] [16] , since P4 withdrawal initiates a rise in CCL2 expression while continued P4 administration prevented the increase in CCL2 expression in the gravid horn of unilateral pregnant rats [16] . A role for colony-stimulating factor 1 (CSF-1, is also known as macrophage-CSF), which enhances cell differentiation into macrophages, has also been suggested as in ovariectomized mice, low levels of CSF-1 correlated with low uterine macrophage numbers suggesting that sex steroids tightly regulate CSF-1 production, indirectly controlling uterine macrophage density [17] . The regulation and function of the increase in the myometrial macrophage, monocyte, and neutrophil numbers around the time of labor is still unclear and the subject of ongoing research. The studies by Norman et al, in the human, highlighted the association between labor and inflammation, demonstrating an intense myometrial leukocyte infiltration in association with increased cytokine expression [1] [2] [3] . Furthermore, inflammation has been found to play a central role in virtually all myometrial gene array studies of laboring myometrium [18] [19] [20] [21] [22] [23] [24] . Inflammatory cells can exert a direct or indirect effect on myometrial contractility, the former by enhancing ROCK activity and the latter via increased cytokine and prostaglandin synthesis [25, 26] . Importantly, P4 can reverse the effect of monocytes on myometrial contractility [26] , consistent with a mutually antagonist relationship between P4 and inflammation, which forms the basis of several theories for the onset of human labor [27] [28] [29] .
Many studies have considered the uterus in isolation, not considering that immune changes in the uterus may reflect changes in the systemic immune system. Furthermore, while P4 has been shown to regulate uterine monocyte trafficking, it could exert effects on the systemic immune system, potentially controlling both the local (myometrial) and systemic immune system. In this study, we initially investigated the behavior of the innate immune system in CD-1 mouse pregnancy, studying the changes in myometrial immune cell trafficking in the context of the changes in other reproductive tissues (placenta and decidua) and the systemic immune system (blood, lung, and liver); we then compared these to local and circulating cytokine levels and related them all to the changes in myometrial prolabor factor levels. The role of P4 in regulating these local and systemic responses was then evaluated by administration of RU486 to produce acute P4 withdrawal and P4 supplementation to reverse late gestation withdrawal.
Materials and methods

Animal study ethical statement and husbandry conditions
CD1 outbred mice were purchased from Charles River (Margate, UK) at 6-8 weeks of age and subsequently housed in open cages at 21 ± 1
• C, on a 12:12 light/dark cycle, and given Harlan Teklad 2018 Global Diet rodent food and water ad libitum. Female mice were mated overnight with males and the day a copulatory plug was observed was designated embryonic day 0 (E0). Stud males were singly housed, whilst females were group housed with up to five others until E18 at which time they were singly housed to litter down.
The health status of all animals was monitored daily, and all mice due to enter a treatment arm were inspected to assure good health prior to initiation of the protocol. The daily subcutaneous injection sites were varied to minimize discomfort to the animals and monitored for any abnormal response. Animals were monitored by infrared CCTV (RF Concepts, Ireland) from E18 (or E16 in the RU86 treatment arm) and physical inspection in the lead up to labor, in case of laboring complications.
All experiments were performed in accordance with the Animals (Scientific Procedures) Act 1986, under Home Office Licenses 70/6909 & 70/7518, with approval from the Animal Welfare & Ethical Review Boards of Imperial College and University College London. The 3Rs and ARRIVE guidelines were consulted and implemented in completion of this study and in the production of this manuscript.
Leukocyte trafficking dynamics during late gestation and labor
The leukocyte populations and subsets were analyzed in late gestation and labor in the uterus and systemically to gain a global understanding of the response to pregnancy and labor. The lungs, liver, blood, and uterus of CD-1 mice were collected from naïve virgin nonpregnant mice (n = 3 mice) and from time-mated mice. In the pregnant mice (E16, E17, and E18 and after the spontaneous delivery of at least one pup for the laboring samples, n = 6 dams per group), myometrium, decidua, and placentas were also collected (gating strategies described previously [30] ). Postnatal samples were obtained within 24 h postdelivery.
Progesterone and RU486 treatment
Animals were selected for each treatment arm randomly, with control and P4-treated animals injected alongside each other to avoid bias i.e. E16 control group treated alongside E16 P4 group (although housed in different cages). Injections and tissue collections were performed at the same time each day and the animals returned to their home cage unless they were due to labor that day, at which point they were singly housed with suitable nest boxes and nesting materials. Due to pregnancy rates and to again avoid collection bias, multiple RU486 time point collections were performed on the same day, whilst laboring samples were collected over various days. We mated enough animals to ensure that we had a minimum of six animals at each time point. This sample size was chosen based on previous in vivo work [31] , the requirements for statistical normality testing, and on initial pilot study results. When the mating proved to be more successful than expected, we used the excess animals to increase numbers at different time points. For tissue collection in all treatment groups, animals were briefly anaesthetized using 5% isoflurane (in 1.5 L/min oxygen) and a cardiac puncture performed using a heparinized syringe, followed by immediate cervical dislocation. The excised tissues immediately processed for flow cytometry or snap-frozen on dry ice prior for later molecular analysis.
Control group
Mice were administered daily subcutaneous peanut oil (P4 vehicle control) injections from gestational day 14 (E14) until gestational day 18 (E18) and an additional subcutaneous injection of DMSO (RU486 vehicle control) on gestational day 16 (E16).
For tissue collection, animals were briefly anaesthetized using 5% isoflurane (in 1.5 L/min oxygen) and a cardiac puncture was performed, followed by immediate cervical dislocation on gestational days 16 (n = 6 dams), 17 (n = 8 dams), 18 (n = 6 dams), and in labor (n = 6 dams), which was identified following delivery of at least the first pup. Tissues were immediately processed for flow cytometry or snap-frozen on dry ice prior to molecular analysis.
RU486 model of preterm labor
Mice were administered daily subcutaneous peanut oil (P4 vehicle control) injections from E14 until E16 and a subcutaneous injection of 150 μg RU486 dissolved in 20 μl DMSO on E16 at 10 am. Tissues were collected at 4.5 h (n = 8 dams), 9 h (n = 8 dams), 13.5 h (n = 6 dams) after RU486 administration and upon delivery of at least the first pup (labor) that took place approximately 18 h after RU486 administration (n = 7 dams). Tissues were immediately processed for flow cytometry or snap-frozen on dry ice prior to molecular analysis.
P4 model of prolonged gestation
Mice were administered a daily subcutaneous injection of 2 mg P4 dissolved in 40 μl peanut oil from E14 until gestational day 20 (E20) and an additional subcutaneous injection of DMSO (RU486 vehicle control) on gestational day 16 (E16). Tissues were collected on days 16 (n = 7 dams), 17 (n = 8 dams), 18 (n = 7 dams), 19 (n = 9 dams), and 20 (n = 7 dams). They were immediately processed for flow cytometry or snap-frozen on dry ice prior to molecular analysis. Circulating P4 levels were maintained on this regimen until E20 (Supplementary Figure S1B) .
Leukocytes were differentiated between vascular and tissue populations by staining with CD45. In the myometrium, the greater majority of leukocytes were within the tissue; in contrast, in the lung and liver, the majority were shown to be a marginalized intravascular (Supplementary Figure S2) .
To label dividing cells in vivo, 100 μl 10 mg/ml BrdU in sterile 1x DPBS was administered by intraperitoneal injection (BD Pharmingen, New Jersey, USA) 6 h before a subcutaneous injection of 150 μg RU486 (n = 3 mice) or DMSO vehicle control (n = 3 mice). Blood and myometrial samples were collected at labor or 24 h after BrdU injection and processed according to the manufacturer's instructions (as described previously [30] ).
CCR2 antagonist administration
Pregnant mice at E16 were given 10 mg of the selective CCR2 antagonist RS504393 (n = 6 dams) (Abcam, Cambridge, UK) by oral gavage 8 h after subcutaneous injection of 150 μg RU486. RS504393 was dissolved in DMSO at a concentration of 4 mg/ml, and diluted 1:20 with PBS so that DMSO concentration was reduced to 5% thereby obtaining a final concentration of 2 mg/kg for in vivo administration. DMSO (5%) in PBS was used as the vehicle control (n = 6 dams). This dose was selected based on CCR2 blockade experiments by Furuichi et al and Kitagawa et al [32, 33] . Blood, lung, and myometrial samples were collected at labor or 12 h after RS504393 oral gavage.
Cell preparation and flow cytometry
Blood was immediately mixed with 5 mM EDTA and stored at 4
• C until analysis within 12 h. The lungs, sections of liver, myometrium, decidua, and placentas were weighed and then immediately homogenized using a gentleMACS M tube (Miltenyi Biotec Ltd, Surrey, UK) containing 1 ml of IC fixation buffer (eBioscience, Hatfield, UK) for 1 min, diluted with 5 ml of PBS, 2% FBS, sodium azide 0.1% 2 mM EDTA and washed twice by centrifugation (400 × g for 5 min) prior storage on ice. The homogenate was then strained through a 40-μm nylon cell strainer (BD Falcon, Oxford, UK), and the cell suspension was then centrifuged at 400 × g for 5 min. Cells were then resuspended in permeabilizing medium PBS, 0.1% sodium azide, 0.5% BSA, and 0.2% saponin, and then incubated with antibodies at 4
• C for 30 min. The following fluorophore-conjugated rat anti-mouse MAbs antibodies were used: Ly6C (HK1.4), Gr1 (RB6-8C5), NK1. Table S1 , S2 and S3). After staining, lysis of red blood cells was performed using FACS lysing solution (BD). Cell counts were determined using AccuCheck counting beads (Invitrogen, Paisley, UK). Samples were run using CyAn ADP Beckman Coulter flow cytometer and Cell Quest 3.3 software. Data were analyzed using FlowJo version 7.6.5.
Multiplex cytokine assays
Tissue lysates were prepared from snap-frozen myometrium and lung samples in Bio-Plex Cell Lysis buffer (BioRad, Hertfordshire, UK) and a Precellys24 (Stretton Scientific Ltd, UK) homogenizer following the manufacturer's instructions. Total protein concentrations were quantified using a DC Protein Assay (BioRad). Whole blood was mixed with 5 mM EDTA immediately and centrifuged at 
Quantitative RT-PCR analysis
Total RNA was extracted from tissue using an RNeasy kit and Qiashredder (Qiagen Ltd, UK). The concentration of RNA in each sample was measured by the NanoDrop ND1000 spectrophotometer (ThermoFisher Scientific, UK). RNA (1.0 μg) was converted to cDNA using the MuLV reverse transcriptase system (Applied Biosystems Ltd, Warrington, UK), according to manufacturer's protocols. Primer sets were designed using Primer3 software (NCBI) and obtained from Invitrogen (Supplementary Table S1 ). Quantitative PCR was performed in the presence of SYBR Green (Roche Diagnostics Ltd, UK), and amplicon yield was monitored by Rotor Gene R-G 3000 (Corbett Research, Australia).
Statistical analysis
All data were tested for normality using a Kolmogorov-Smirnov test. Normally distributed data were analyzed using a Student t test for two groups and an analysis of variance (ANOVA) followed by a Bonferroni post hoc test for three groups or more. Data that were not normally distributed were analyzed using a Mann-Whitney test for unpaired data and when comparing three groups or more a KruskalWallis test, with a Dunn multiple comparisons post hoc test. P < 0.05 was considered statistically significant.
Results
Initially, in naïve mice, we determined the changes in the local and systemic innate immune system, myometrial cytokine levels, and prolabor gene expression in late mouse pregnancy. Then, we investigated the role of P4 in these changes by (i) provoking P4-withdrawal by administering RU486 (a P4 antagonist) on E16 and (ii) preventing the usual systemic withdrawal of P4 by giving 2 mg of P4 daily from E14.
Naïve pregnant CD-1 mouse: immune cell trafficking in normal pregnancy
To evaluate innate cell trafficking by flow cytometry, we focused on neutrophils, Ly-6C HI monocytes, and macrophages as the principle myeloid subpopulations implicated in previous studies. Data for Ly6c LO monocytes were obtained, but only for blood and lungs, where these populations can be identified clearly and distinguished from resident macrophages [34] . The nonpregnant mice were sacrificed at different stages of the estrous cycle and this may account for the variation in the cell numbers.
(i) Myometrium: Myometrial neutrophil density peaked on E18 (vs. NP, E16 and E17 P < 0.0001, Figure 1A ), but decreased with the onset of labor (vs. E18, P < 0.05 Figure 1A ). Similarly, Ly-6C HI monocyte subset cell density increased (E18 vs. E16, P < 0.05 and E18 vs. NP, P < 0.001, Figure 1B ) and decreased with labor (P < 0.01, Figure 1B Figure 1C ) and tended to decline with the onset of labor ( Figure 1C ). The Ly-6C HI monocyte population did not change significantly ( Figure 1D ). (v) Lungs: Neutrophil numbers peaked on E17 (vs. NP, P < 0.05, Supplementary Figure S3E ) and remained stable thereafter. The Ly-6C HI monocyte population peaked on day 18 (P < 0.05) and tended to decline with the onset of labor (Supplementary Figure S3F) . (vi) Liver: Neutrophils peaked on E17 (vs. E16, P < 0.05) and remained stable thereafter (Supplementary Figure S3G) . The Ly-6C HI monocyte population remained unchanged (Supplementary Figure S3H) . The Ly-6C LO monocyte populations in blood and lungs remained unchanged and were not studied further (Supplementary Figure S4A and B). Myometrial macrophage numbers were greater during pregnancy (E16, E17, E18 vs. NP, P < 0.05, 0.01, and 0.001 respectively, Supplementary Figure S5A ), but declined with the onset of labor (P < 0.05, Supplementary Figure S5A ). Placental and decidual macrophage numbers did not change through pregnancy (Supplementary Figure S5B and C). And the markers of macrophage activation remained stable (COX-2) or declined (CD-86) with advancing gestation in myometrium and decidua (Supplementary Figure S6A-D) . The reduction in myometrial macrophage numbers was not related to increased rates of apoptosis (Supplementary Figure  S7A) . In postnatal studies, both neutrophils and Ly-6C HI monocyte populations increased in the myometrium and decidua (all P < 0.05, Supplementary Figure S8A -D). In contrast, macrophage numbers declined further in the myometrium (P < 0.01, Supplementary Figure S9A ) and tended to decline in the decidua too (Supplementary Figure S9B) . Subsequent studies focused on the trafficking of neutrophil and Ly-6C HI monocytes in the myometrium, placenta, blood, and lungs only.
Naïve pregnant mouse: myometrial and systemic cytokine levels
We investigated whether the leukocyte migration into the myometrium was due to a chemokine gradient and associated with increased inflammatory cytokine levels by measuring chemokine and cytokine mRNA and protein levels in the myometrium. IL-1β, IL-6, CCL2, and CXCL2 mRNA expression increased in laboring myometrium (P < 0.05-0.01 Figure 2A -D). Myometrial CCL2 protein levels (P = 0.06, E16 vs. E18), CXCL1, and IL-6 tended to increase with gestation, but were not significantly increased until the onset of labor ( Figure 2E-H) . Interestingly, the mRNA and protein levels of IL-1α and, to a lesser extent, IFNγ declined from day 17 to labor (Supplementary Figure S10A , E and C, G), in parallel with circulating P4 levels (Supplementary Figure S1A) . CCL5 mRNA increased with labor but protein levels remained unchanged, and GM-CSF levels of both mRNA and protein remained unchanged (Supplementary Figure S10B , F and D, H). Circulating levels of IL-1β, IL-6, and TNFα remained unchanged with advancing gestation and parturition (Supplementary Figure  S11B-D) . IL-1α levels were higher on day 17 than on day 16 and during parturition than on day 18 (both P < 0.05, Supplementary Figure S11A ). CCL2 levels increased significantly with the onset of labor compared to E18 (P < 0.05, Supplementary Figure S11E) . Levels of CXCL1 were greater on day 17 of pregnancy compared to levels on days 16 and 18 (both P < 0.05, Supplementary Figure 18, and laboring CD1 mice was quantified using flow cytometry (cells/g or ml). Data are expressed as individual data points with median and interquartile range superimposed. Nonpregnant, E16, E17, and E18 cell densities were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with Dunns post test when data were not ( * = P < 0.05, * * = P < 0.01, * * * = P < 0.001 and * * * * = P < 0.0001, n = 6-14).
Figure 2. (A-H) Myometrial cytokine (IL-1β
, IL-6, CCL2, and CXCL1) mRNA expression (housekeeping gene Hprt) and levels (pg/ml) measured by quantitative RT-PCR and multiplex respectively. Data are expressed as individual data points with median and interquartile range superimposed and were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not ( * = P < 0.05 and * * = P < 0.01, n = 6). S11G). Interestingly, G-CSF (essential for neutrophil mobilization) levels behaved similarly (day 17 vs. day 16, P < 0.01 and vs. day 18 < 0.001, Supplementary Figure S11J ).
Since the changes in circulating cytokines were slight, subsequent studies focused on the myometrial cytokine levels.
Naïve pregnant mouse: myometrial prolabor factor levels
The expression of Cx-43 and COX-2 mRNA peaked in labor (P < 0.05-0.01 vs. days 16-18 and P < 0.05-0.001 vs. days [16] [17] [18] respectively, Figure 3A and B). Protein levels of COX-2 and Cx-43 also peaked in labor (P < 0.05 vs. day 18 and P < 0.001 vs. day 18 respectively, Figure 3C and D).
Naïve pregnant mouse: systemic P4 levels P4 levels in the serum were measured throughout late gestation and in nonpregnant animals (Supplementary Figure S1A) . Circulating P4 levels decline from gestation day 14 to labor, which correlates with an increase in infiltrating leukocytes to the myometrium. To investigate the relationship between P4 and leukocyte dynamics further, we studied the impact of RU486 (a P4 and glucocorticoid receptor antagonist) administration and P4 supplementation and were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not ( * = P < 0.05, * * = P < 0.01 and * * * = P < 0.001, n = 6).
(Supplementary Figure S1B ) on leukocyte trafficking, myometrial cytokine, and prolabor levels.
The role of P4: RU486
Administration of 150 μg RU486 on E16 resulted in preterm labor within 17.3 ± 1.0 h (mean ± SEM, Supplementary Figure S12 ). Samples were obtained before treatment, at three intermediate time points (4.5, 9, and 13.5 h post-RU486) and in labor.
RU486: immune cell trafficking
(i) Myometrial neutrophil cell density increased with time after RU486 administration, and was significantly raised at 9 h and during parturition vs. E16 values (P < 0.05 and P < 0.001 respectively, Figure 4A ). Myometrial Ly-6C HI monocyte density increased with the onset of parturition (P < 0.001 vs. all time points, Figure 4B ). (ii) Placental Ly-6C HI monocyte density declined with time (E16 vs. 4.5, 9, and 13.5 h, all P < 0.01, Supplementary Figure S13B ), although levels increased again in labor (vs. 9 h, P < 0.05, Supplementary Figure S13B) ; there was no effect on neutrophil numbers. (iii) Blood neutrophil numbers peaked at 9 h (vs. E16, P < 0.05, Figure 4C ); Ly-6C HI monocytes increased to a peak at 9 h and then declined before rising again in parturition (both P < 0.05, Figure 4D ). (iv) Lung neutrophil (labor vs. E16 and vs. 13.5 h, P < 0.01 and 0.05 respectively, Supplementary Figure S13C ) and Ly-6C HI monocyte (labor vs. E16, P < 0.001, Supplementary Figure S13D ) numbers peaked with parturition. (v) Macrophage numbers increased in the myometrium, but not placenta, with parturition (P < 0.05 vs. E16 and 9 h, Supplementary Figure S14A and B).
RU486: myometrial cytokine levels
Cytokine mRNA expression only increased with parturition (IL-1β, IL-6, CCL2, and CXCL1, Figure 5A -D); however, protein levels of IL-6, CCL2, and CXCL1 all rose earlier, peaking at 9 h (P < 0.05-0.01 vs. E16, Figure 5F -H). A similar phenomenon was observed for IL-1α and TNFα (Supplementary Figure S15A , B, E, F). CXCL2 mRNA levels did not change, but protein levels peaked at 9 h post-RU486 (Supplementary Figure S15D and H). The mRNA levels of IL-4, IL-10, and IFN all remained stable, while their protein Cell density (cells/g or cells/ml) was quantified using flow cytometry. Data are expressed as individual data points with median and interquartile range superimposed and were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not ( * = P < 0.05 and * * * = P < 0.001, n = 6-10). Data are expressed as individual data points with median and interquartile range superimposed and were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with Dunns post test when data were not ( * = P < 0.05, * * = P < 0.01, * * * = P < 0.001 and * * * * = P < 0.0001, n = 6).
levels peaked at 4.5 h and declined thereafter (Supplementary Figure  S16A- C and E-G). Like IL-1β ( Figure 5A and E), CCL5 mRNA levels peaked in labor, but protein levels remained unchanged (Supplementary Figure S16C and G).
RU486: myometrial prolabor factor levels
The expression of Cx-43 mRNA peaked in labor (P < 0.01 vs. E16 and E17 and P < 0.05 vs. 4.5 h, Figure 6A ) and of COX-2 mRNA tended to increase to labor; protein levels of Cx-43 peaked at 13.5 h (P < 0.0001 vs. day E16, Figure 6D ) and of COX-2 declined to a nadir in labor (P < 0.05 vs. E16, Figure 6E ). OTR mRNA peaked at 9 h (Supplementary Figure S17A) ; despite multiple attempts, the western analysis for OTR was inconsistent (data not shown).
RU486: myometrial MAPK and NFκB
The phosphorylation of p38 peaked at 9 h (P < 0.05 vs. E16 and labor, Figure 7A ) and was higher at 4.5 h than in labor (P < 0.05, Figure 7B ). JNK phosphorylation was greater at 4.5 h vs. labor Data are expressed as individual data points with median and interquartile range superimposed and were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not ( * = P < 0.05, * * = P < 0.01 and * * * * = P < 0.0001, n = 5-8).
(P < 0.01) and at 9 h vs. labor (P < 0.05, Figure 7B ). The phosphorylation of c-jun peaked at 4.5 h (P < 0.05 vs. E16, Figure 7C ). Both ERK1/2 and p65 phosphorylation tended to increase, peaking at 9 h (Supplementary Figure S18A and B).
RU486: CCR2 antagonist
The delivery time after PTL induced by RU486 in vehicle controls and mice given the CCR2 antagonist RS504393 was similar (Supplementary Figure S19 ), although circulating Ly-6C HI monocytes (P < 0.05, Supplementary Figure S20F ) and myometrial neutrophils (P < 0.05, Supplementary Figure S20A ), but not Ly-6C HI monocytes (P = 0.062, Supplementary Figure S20B) , were significantly reduced.
The role of P4: P4 supplementation
Mice were given a daily subcutaneous injection of 2 mg P4 dissolved in 40 μl peanut oil from E14 until E20 when the animals were culled. On E20, the pups were dead and appeared to be wedged into the pelvis. Pairwise comparisons were made with vehicle-treated mice to E19; samples from P4-supplemented mice on E18, E19, and E20 were then compared longitudinally. Initial studies were carried out in nonpregnant CD-1 mice given 2 mg of P4 in 40 μl peanut oil via a subcutaneous injection daily for 5 days. Only the cell density (cells/g) of myometrial neutrophils declined with P4 treatment (P < 0.05, Supplementary Figure S21A ).
P4 supplementation: immune cell trafficking (i) Myometrium: P4 supplementation had no effect on neutrophil numbers (they were actually higher on E19 in the P4-treated group P < 0.01, Figure 8A ), but did reduce the prelabor infiltration of Ly-6C
HI monocytes (E17 P < 0.01 and E18 P < 0.001, Figure   8B ). From day 18 in P4-supplemented mice, neutrophils (E18 vs. E19, P < 0.05, Figure 8C ) and monocytes (E18 vs. E19 and E20, P < 0.01, Figure 8D ) increased on E19 and remained high on E20.
(ii) Placenta: On E19, neutrophils (P < 0.001, Supplementary Figure S22A ) and Ly-6C HI monocytes (P < 0.0001, Supplementary Figure S22B ) were lower in the P4-supplemented group. Neutrophils (E20 vs. E18, P < 0.0001 and E20 vs. E19, P < 0.001, Supplementary Figure S22C ) and monocytes (E20 vs. E19 and E18, both P < 0.0001, Supplementary Figure S22D ) were higher on E20 in the P4-supplemented mice. (iii) Peripheral blood neutrophils (P < 0.01, Figure 8E ) and Ly-6C HI monocytes (P < 0.01, Figure 8F) were lower in P4-supplemented pregnant mice on E19. On E20 in P4-supplemented mice, neutrophils (E20 vs. E18, P < 0.01 and E20 vs. E19, P < 0.001 Figure 8G ) and monocytes (E20 vs. E18, P < 0.05 and E20 vs. E19 P < 0.001, Figure 8H ) were increased. (iv) Lungs: On E19, Ly-6C HI monocytes were lower in the P4-supplemented animals (P < 0.01, Supplementary Figure S22F) . Again, on E20 in P4-supplemented mice, neutrophils (E20 vs. E18, P < 0.05, Supplementary Figure S22G ) and monocytes (E20 vs. E19 and E18, P < 0.01 and P < 0.001 respectively, Supplementary Figure S22H ) were higher. (v) Macrophages: Myometrial (P < 0.05) and placental (P < 0.01) macrophages were lower in P4-treated mice on E19, (Supplementary Figure S23A and B). However, in contrast to other cell types, macrophage numbers did not rise from E18, but actually declined in the myometrium (P < 0.05, Supplementary Figure S23C ) and remained static in the placenta (Supplementary Figure S23D ).
P4 supplementation: myometrial cytokine levels
Cytokine mRNA expression was greater with parturition in vehicletreated mice compared to E19 P4-treated mice (IL-6, P < 0.05, Figure 9B ; IL-1α and TNFα, P < 0.05 and P < 0.01 respectively, Supplementary Figure S24A and B and IL-10 Supplementary Figure S25C ). However, protein levels were unchanged in all cases ( Figure 9E -H and Supplementary Figures S24E-H and S25D-F) except for CCL2, where they were greater in vehicle-treated mice on E18 (P < 0.05, Figure 9G ). With prolonged P4 supplementation (E18-E20), although mRNA levels for inflammatory cytokines and chemokines remained stable, the respective protein levels rose in all cases except CCL5 and GCSF ( Figure 10 and Supplementary Figures S26 and S27 ).
P4 supplementation: myometrial prolabor factor levels
Surprisingly, on E17, Cx-43 and OTR mRNA expression was greater in P4-supplemented mice (P < 0.05 and P < 0.001 respectively, Figure 11A and Supplementary Figure S17B) ; on E18 mRNA expression was similar; and on E19, the expression of Cx-43, COX-2, and OTR mRNA was greater in laboring vehicle-treated mice (all P < 0.01 Figure 11A and B; Supplementary Figure S17B ). Cx-43 and COX-2 mRNA expression did not change with prolonged P4 treatment ( Figure 11C and D) . In all cases, there were no differences in the protein levels ( Figure 11E -H).
P4 supplementation: myometrial MAPK and NFκB P4 treatment had no consistent effect of MAPK/NFkB activation. The phosphorylation of p38 was greater in vehicle-treated mice on E17 only (P < 0.05, Figure 12B ), JNK in P4-supplemented mice on E19 (P < 0.05, Figure 12C ) and c-jun on E16 in vehicle-treated mice ( Figure 12H ). There were no differences in ERK1/2 and p65 phosphorylation (Supplementary Figure S28) .
The role of P4: myometrial levels of inflammatory cytokines in labor
Myometrial cytokine levels were compared in mice after a spontaneous and RU486-induced onset of parturition and on day 19 of P4 treatment. Interestingly, only CCL2 levels were greater in the RU486-induced labor than in the spontaneous labor (P < 0.05, Supplementary Figure S29E) .
The results of the studies are summarized in Table 1 .
Discussion
This study shows that during pregnancy (i) there is a P4-regulated monocyte infiltration into the myometrium; (ii) P4 regulates cytokine and prolabor factor synthesis in the myometrium via mRNAdependent and independent mechanisms; and (iii) with prolonged progesterone daily dissolved in 40 μl peanut oil from E14 until E20. Cell density (cells/g) was quantified using flow cytometry. Comparative data (P4 supplemented vs. vehicle) shown until E19 (A, B, E, F), when vehicle-treated mice delivered. Thereafter, the data are shown between E18 and E20 for P4-supplemented mice alone (C, D, G, H). The data are expressed as individual data points with median and interquartile range superimposed. Paired data were analyzed using an unpaired t-test when normally distributed and a Mann-Whitney test when data were not. Longitudinal data were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not ( * * = P < 0.01 and * * * = P < 0.001, n = 6-10).
P4 supplementation, P4 repression of prolabor gene expression was maintained, but its ability to control the local and systemic innate immune system was lost, consistent with the development of a limited functional withdrawal of P4 action in mouse parturition.
In terms of immune function, we found increased immune cell infiltration of the myometrium but not in the decidua or placenta prior to parturition. However, despite the marked increase in leukocyte extravasation, there was no coincident increase in inflammatory cytokines, either at the mRNA or protein level, raising the possibility that inflammation occurs only after the onset of labor and questioning the role of leukocytes and inflammatory cytokines in the onset of labor. Indeed, in RU486-induced parturition, the CCL-2-mediated increase in myometrial leukocyte infiltration was reduced by treatment with a CCR2 antagonist, but the interval to parturition was not affected.
These data are important as they show that P4 prolongs gestation through the repression of myometrial prolabor and inflammatory gene expression. The former seems to be mediated through , and CXCL1) mRNA expression (housekeeping gene GAPDH) and levels (pg/ml) measured by quantitative RT-PCR and multiplex respectively. In myometrial samples from pregnant control mice and CD-1 mice given 2 mg progesterone dissolved in 40 μl peanut oil from E14 until E20. Comparative data (P4 supplemented vs. vehicle) shown until E19 (A, B, E, F), when vehicle-treated mice delivered. Thereafter, the data are shown between E18 and E20 for P4-supplemented mice alone (C, D, G, H). The data are expressed as individual data points with median and interquartile range superimposed and were analyzed using an unpaired t-test when normally distributed and a Mann-Whitney test when data were not ( * = P < 0.05, n = 6). , and CXCL1) mRNA expression (housekeeping gene GAPDH) and levels (pg/ml) measured by quantitative RT-PCR and multiplex respectively. In myometrial samples on E18, 19, and 20 from pregnant CD-1 mice given 2 mg progesterone dissolved in 40 μl peanut oil from E14 until E20. Data are expressed as individual data points with median and interquartile range superimposed and were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not ( * = P < 0.05 and * * = P < 0.01, n = 6).
repression of mRNA expression, but the latter seems to be mediated through both an mRNA-dependent and independent mechanism, perhaps involving MAPK regulation of tristetraprolin (TTP) as we have recently reported to occur in human labor (Lei et al, 2017 unpublished observation). Finally, they show that a functional withdrawal of P4 action does occur, albeit limited to myometrial cytokine levels, but importantly, this occurs without any change in mRNA expression, hinting that our failure to identify a consistent mRNA signature of parturition in the human may be because the important changes occur at the protein level, perhaps induced through a change in kinase activity. Equally, the myometrium is not a homogeneous tissue, it contains many different cell types and P4-dependent effects will be modulated by changes in myometrial cell content and their relative P4 responsiveness. Similarly, the mismatch between mRNA and protein may be due to the heterogeneity of the tissue or possibly differences in protein and mRNA assay sensitivity.
Naïve mouse studies Myometrium leukocyte changes
We found that leukocytes increased in the myometrium only, intriguingly peaking on E18 and declining with parturition, only to increase again postdelivery. These changes occurred in the absence of changes in the leukocyte numbers in the decidua or placenta, which implies the existence of a specific myometrial immune regulation. Our monocyte and neutrophil data are similar to those of Shynlova et al, but differ in that the postnatal increase was less marked, perhaps because our samples were obtained up to 24 h postdelivery, rather than by 6 h [13] . We found no change in macrophage (CD11b+, F4/80 high cells) densities in any reproductive tissues or in their activation markers in contrast to the myometrial data of Shynlova et al, who found that myometrial macrophage numbers were higher on E18 compared to E15 [13] and the decidual data from Hamilton et al, who found that in the rat, macrophage numbers In myometrial samples obtained from pregnant control mice and CD-1 mice given 2 mg progesterone dissolved in 40 μl peanut oil from E14 until gestational E20. Comparative data shown until E19 and longitudinal data E18-E20. Data are expressed as individual data points with median and interquartile range superimposed. Paired data were analyzed using an unpaired t-test when normally distributed and a Mann-Whitney test when data were not. Longitudinal data were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not ( * = P < 0.05 and * * = P < 0.01, n = 5-8).
Figure 12. (A-F) Myometrial phospho-p38 (p38, A, D), phospho-JNK (pJNK, B, E), and phospho-cjun (p-c-jun, C, F) measured by western analysis in myometrial
samples obtained from pregnant control mice and CD-1 mice given 2 mg progesterone dissolved in 40 μl peanut oil from E14 until gestational E20. Comparative data shown until E19 and longitudinal data from E18-E20. Data are expressed as individual data points with median and interquartile range superimposed. Paired data were analyzed using an unpaired t-test when normally distributed and a Mann-Whitney test when data were not. Longitudinal data were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not ( * = P < 0.05, n = 5-8). increased immediately before parturition [11] . Both Shynlova et al and we found that macrophage numbers declined in the myometrium postdelivery, at a time when macrophages might have been expected to be playing an active role in tissue repair/remodeling. The increase in myometrial leukocyte density was associated with a trend for an increase in the levels of CXCL1, CCL2, and CCL5 between E17 and E18, but with no change in gene expression. Shynlova et al also related myometrial cytokine levels to leukocyte numbers, on E15, E18, the day of parturition, and postdelivery of mouse pregnancy; they found that macrophages were highest on E18, but neutrophils and monocytes peaked in postnatal samples, with no significant increase on E18 compared to E15, similar to the changes in myometrial chemokines, which were only measured at three times points, E15, after the onset of parturition and postdelivery, missing E18 [13] . In an earlier paper, Shynlova et al studied myometrial CCL2 levels in rat pregnancy in more detail and found that the levels of both mRNA and protein increased before the onset of labor on day 22 of gestation, consistent with the trends we observed [16] . The authors related the increase in CCL2 to a preparturition increase in macrophage numbers as assessed by immunohistochemistry [16] and suggested that the increase in myometrial CCL2 was stretch induced and triggered by the decline in systemic P4 levels. Systemic leukocyte changes Circulating neutrophils were higher during pregnancy than in nonpregnant mice, but did not change in late pregnancy and actually tended to decline with parturition. In the lung and liver, marginated (i.e. adherent to the vessel endothelium) neutrophils peaked on E17, while monocytes interestingly peaked on day 18. As shown in Supplementary Figure S4 , most of these cells were intravascular, and were termed marginated, rather than infiltrating as seen for virtually all myometrial leukocyte populations. The increase in marginated neutrophils may simply reflect the increase in circulating numbers, whereas the increase in monocytes occurred on the background of stable circulating numbers and implies a systemic activation with increased trapping of cells within the pulmonary microcirculation. Whether the increase in circulating leukocytes contributed to the increase in myometrial leukocytes is uncertain. In the naïve mice, the similarity in the patterns suggests that they may be related, but the absence of any change in placenta or decidua implies either that immune suppression restricted the influx of leukocytes in these sites or that local factors contributed to the increase in the myometrium.
Prolabor factors
Cx-43 and COX-2 mRNA and protein each increased with the onset of parturition. Shynlova et al in the mouse and Helguera et al in the rat reported similar changes, but both only used one time point prior to labor, E15 (mouse) and E21 (rat), respectively, making direct comparisons with the current study difficult [16, 35] , Arthur et al, in a more detailed study of myometrial gene expression in the rat, found no prelabor increase in either Cx-43 or COX-2 mRNA [36] . Similarly, previously, we showed no difference in Cx-43 or COX-2 mouse myometrial protein levels between E16 and E18 samples [31] , supporting the idea that the increase in prolabor protein levels is tightly temporally regulated, with the increase occurring very close to or simultaneously with the onset of labor.
The role of P4
Giving RU486 on E16 triggered parturition 17 h later and, conversely, supplementing P4 from E14 prevented the onset of term labor. At 4.5 h after RU486, neutrophil numbers increased in the myometrium, blood, and lung; the myometrial MAPK system was activated and the myometrial levels of several cytokines and Cx-43 were increased. These data suggest that the increase in inflammation and prolabor factors in spontaneously laboring mice may take place within hours of the onset of labor and, consequently, defining whether inflammation occurs prior to the onset of parturition, with the implication of a possible causative role, will be difficult. In humans, although there is evidence of an increase in transcription factor activation in early labor, there is no increase in cytokine levels until labor is established suggesting that inflammation is a consequence rather than a cause of labor (see above for comments about differential assay sensitivity and myometrial composition [37] ). This may well be true in the mouse as well, but this awaits further studies. RU486 is both a PR and GR antagonist, some of its effects may be related to inhibition of GR. Also, in contrast to the gradual decline in P4 levels in normal pregnancy, RU486 acutely blocks P4 action, completely changing the time scale of the decline in P4 action.
RU486, myometrium leukocyte changes
After RU486 treatment, myometrial neutrophil numbers increased significantly at 9 h and in labor, and Ly-6C HI monocyte numbers increased at the time of labor. Myometrial chemokine levels, including CCL2, CXCL1, and CXCL2, increased from 4.5 to 9 h, intriguingly without any increase in mRNA abundance myometrium total RNA, and probably accounted for the increase in myometrial leukocyte numbers. The apparent differential effect on neutrophils and monocytes, although typical of the classical kinetics of these two cell types, is difficult to explain given the similar changes in chemotactic factors. An increase in inflammatory cytokine mRNA abundance was only detectable in labor, but again the actual protein levels of all but IL-1β increased at between 4.5 and 9 h (more striking changes were seen for IL-4, IL-10, and IFNγ , supplementary data). Similar to myometrial Ly-6C HI monocyte numbers, myometrial macrophage numbers increased after the onset of RU486-induced parturition, suggesting that the change may be a consequence rather than a cause of parturition. Interestingly, Shynlova et al did not find any difference in myometrial macrophage, neutrophil, or monocyte numbers in RU486-induced parturition compared to E15 levels and although they did report increases in IL-6 at mRNA and protein levels, chemokine levels were also not increased [13] . The absence of any significant change in myometrial cytokine levels in Shynlova et al's study may be because the analysis included postnatal samples in which cytokine levels were markedly raised, possibly obscuring the significance of the changes seen at the time of RU486-induced parturition [13] .
RU486, systemic leukocyte changes
In this study, RU486 administration increased circulating neutrophils before the onset of labor, but lung margination for both neutrophils and Ly-6C HI monocytes only increased after the onset of labor. These data show that RU486 regulates the systemic and the local maternal immune system, affecting neutrophil bone marrow release and to a lesser extent neutrophil and monocyte activation. RU486 restores adaptive humoral and cellular immune function in LPS-immunosuppressed mice, supporting a systemic effect [38] . RU486 acts as both a glucocorticoid and P4 receptor antagonist, meaning either pathway may be responsible for these effects, but since we observed increased lung margination for neutrophils (E17) and Ly-6C HI monocytes (E18) in the naïve mouse coincident with the decline in circulating P4, it suggests that this is a progesteronemediated effect and consequently that P4 regulates both the systemic and local innate immune system.
RU486, prolabor factors
As reported by Shynlova et al [13] , Cx-43 mRNA and protein levels appeared to increase in tandem, although a nonsignificant increase in Cx-43 protein levels appeared to occur before changes in mRNA abundance. Interestingly, the MAPK system was also activated between 4.5 and 9 h and, in another study, myocardial p38 activation has been associated with enhanced translation of COX-2 mRNA, whereby COX-2 protein levels were increased without any change in mRNA expression [39] . This may explain the increase in protein levels without any apparent change in mRNA abundance. However, in the present study after RU486, COX-2 mRNA did not change significantly and protein levels actually declined. We found a similar increase in cytokine levels in human myometrium in established labor without any apparent increase in mRNA levels (Lei et al, unpublished data). These changes were associated with p38 activation and a decline in TTP, which is a key member of TIS11 family, which has been implicated in mRNA transcription, splicing, polyadenylation, translation, and degradation [40] .
P4 supplementation, myometrium leukocyte changes
Unlike the repressive effect of P4 supplementation on myometrial CCL2 levels and consequently the Ly-6C HI monocyte population, P4 supplementation had no effect on CXCL1/2 levels or neutrophil migration into the myometrium, despite the fact that P4 represses CXCL1 and CXCL2 in vascular endothelial cultures [41] . These data suggest that P4 supplementation has differential effects on myometrial chemokine expression and that an increase in neutrophils alone is not sufficient to induce parturition. RU486 increased both monocyte and neutrophil myometrial infiltration, in association with an increase in CCL2, CXCL1, and CXCL2, suggesting that P4 may repress both monocyte and neutrophil chemotactic factors. Myometrial cytokine levels were similar in both P4-supplemented and naïve mice with the exception of CCL2 on E18, which were higher in naïve mice, perhaps accounting for the difference in myometrial Ly-6C HI monocytes numbers. Indeed, Tagliani et al found that Ly-6C HI monocyte infiltration into the myometrium at E9/10 was CCR2 mediated [10] . In terms of prolabor factors, intriguingly, both Cx-43 and OTR mRNA abundance were greater in the P4-supplemented mice on E17, but at the onset of labor the abundance of Cx-43, OTR, and COX-2 mRNA was consistently greater in the myometrium of the control, vehicle-treated mice. However, no difference could be seen at the protein level at any point. The changes in the RU486-treated and P4-supplemented mice suggest that P4 regulates CCL2 levels and consequently myometrial Ly-6C HI monocyte numbers. To test this hypothesis, we administered the CCR2 antagonist RS 504393 8h after RU486 administration during the phase of monocyte mobilization from the bone marrow into the blood and before myometrial infiltration. The reduction in circulating Ly-6C HI monocyte numbers by RS 504393 confirmed effective blockade of the CCR2 receptor; however, Ly-6C HI monocytes were not significantly reduced in the myometrium, although there was a trend (P = 0.0628). It is possible that Ly-6C HI monocyte infiltration had started prior to RS 504393 administration or that other factors, such as CCL5 or CCL20 [42, 43] , also contributed to myometrial Ly-6C HI monocyte recruitment. Interestingly, the neutrophil cell density in the myometrium was significantly reduced by CCR2 antagonism. Neutrophil CCR2 expression is induced by chronic inflammation and found in a mouse model of polymicrobial sepsis [44, 45] . It is possible that the administration of RU486 induced neutrophil CCR2 expression, or that pregnancy itself induces such a change. However, P4 supplementation did not inhibit the increase in myometrial neutrophil numbers, suggesting that RU486 makes neutrophils sensitive to CCL2 rather than any pregnancy-induced effect. Further, in a study using broad-spectrum chemokine inhibitors (BSCI) in an inflammation-induced mouse model of preterm labor, parturition was delayed to term in 36% of BSCI-treated mice and this coincided with a significant reduction in myometrial neutrophil numbers [46] . However, BSCI treatment alone did not delay the spontaneous onset of parturition at term, suggesting that different pathways mediate the spontaneous onset of labor.
P4 supplementation and systemic leukocyte changes P4 supplementation prevented the labor-associated increase in both neutrophil and Ly-6C HI monocyte numbers in the blood and, for
Ly-6C HI monocytes, in the lungs. This may be a direct effect of P4 on bone marrow release or leukocyte activation, but it could also be mediated though P4-inhibition of parturition.
Effect of P4 supplementation on prolabor factors
In terms of prolabor factors, both Cx-43 and OTR mRNA (Supplementary Figure S17 ) were greater in the P4-supplemented mice on E17, but with the onset of labor the expression Cx-43, OTR, and COX-2 mRNA was consistently greater in the myometrium of the control, vehicle-treated mice. However, no difference could be seen at the protein level at any point, perhaps because of the lack of sensitivity of the western blotting, although Cx-43 tended to be higher in the control mice. Not surprisingly, we failed to see any consistent changes in MAPK/c-Jun activation with P4 supplementation, since, as we saw in the RU486 study, these pathways are tightly temporally regulated close to the onset of labor; furthermore, activation of the MAPK/AP-1 system is followed by de-activation and a persisting repression which will make it appear that activity is reduced [47] .
Functional P4 withdrawal
With advancing gestation in the naïve mice, we observed a trend for chemokine levels to increase with no evidence of an increase in mRNA expression. We observed a similar but more marked occurrence after RU486 and with prolonged P4 supplementation. The effect of RU486 implies that inhibition of P4 action results in an increase in chemokine levels independent of mRNA expression. The similar pattern after prolonged P4 supplementation suggests the development of a functional withdrawal of P4 action, a phenomenon suggested to underpin the onset of human labor. The trends in chemokine levels at the end of naïve mouse pregnancy suggest that this process may also be active during naïve mouse pregnancy. Interestingly, the disconnect between mRNA abundance and protein levels was not observed for prolabor factors and while their expression was increased at the end of naïve mouse pregnancy and after RU486, there was no increase with prolonged P4 gestation. Leukocyte numbers were increased in all compartments with prolonged P4 supplementation; this may be secondary to the change in chemokine levels, but raises the possibility of a systemic withdrawal of P4 effects. Alternatively, the prolonged pregnancy may have resulted in an inflammatory response and secondary increase in leukocyte numbers, particularly since at the time of culling the pups were dead and appeared to be wedged into the pelvis.
Functional significance of the myometrial leukocyte infiltration
In naïve mice, myometrial neutrophil and Ly-6C HI monocyte numbers increased before the onset of parturition, suggesting that they may have a role in its onset. However, there was no evidence of any increase inflammatory cytokine levels until labor was established, suggesting that although leukocyte numbers were increased that the onset of labor was not mediated through an increase in inflammatory cytokine levels. It is possible that the increase in inflammatory cytokine levels occurred later, closer to the onset of parturition and we explored this possibility with RU486 and found that neutrophil numbers increased rapidly after RU486 administration coincident with the increase in inflammatory cytokine levels raising the possibility that P4 controls the onset of parturition through regulating leukocyte numbers and their release of cytokines. However, although P4 supplementation prevented the onset of labor, it only repressed the increase in myometrial Ly-6C HI monocyte, but not neutrophil, numbers, suggesting that neutrophils are not sufficient on their own to drive the onset of labor. Indeed, depletion of neutrophils did not prevent inflammation induced preterm labor in the mouse [48, 49] , questioning the importance of neutrophils in the process of mouse parturition. Given these data, we gave a specific CCL-2 antagonist, RS504393, after RU486 administration. The CCL-2 antagonist reduced the increase in myometrial neutrophils and, to a lesser extent, Ly-6C HI monocytes, but did not prevent or even delay Downloaded from https://academic.oup.com/biolreprod/article-abstract/98/3/376/4628035 by OUP site access user on 08 October 2018 RU486-induced parturition. Together, these data suggest that the ability of RU486 to induce parturition is independent of its ability to increase myometrial leukocyte numbers and, conversely, that the ability of P4 to prolong pregnancy is independent of its ability to delay myometrial Ly-6C HI monocyte infiltration. Overall, these data add more weight to the suggestion that despite being present in abundant numbers, leukocytes have no role in the process of mouse parturition.
The anti-inflammatory properties of P4 P4 has been shown to repress inflammation in a number of experimental situations. Originally, in cell line experiments, P4 acting via the progesterone receptor B isoform has been shown to inhibit NFκB activation [50] . Similarly, in primary human myometrial cells, myometrial cell lines and human myometrial explants, P4 has been shown to exert a similar effect [27, 51, 52] . However, latterly, P4 has been shown to inhibit the AP-1 system through the induction of MKP-1 expression [47] . On the basis of these data, we chose to study the MAPK/AP-1 and p65/NFκB systems in this study. The data here, particularly with RU486, support the idea that P4 acts via inhibition of the MAPK-AP-1 system to inhibit proinflammatory gene expression and limit the inflammatory cell myometrial infiltration.
Conclusion
These data show that P4 represses myometrial prolabor and inflammatory gene expression through mRNA-dependent and independent mechanisms, the latter possibly involving p38 inhibition and the prevention of mRNA translation. They cast further doubt on the importance of inflammation in the onset of labor, showing that inhibition of the RU486-induced leukocyte infiltration does not delay the onset of parturition. Furthermore, they demonstrate that a functional withdrawal of P4 action does occur and that this is associated with increases in inflammatory cytokines in the absence of any change in mRNA levels, suggesting that assessing the myometrial proteome may hold promise in our search to understand the onset of human labor.
Supplementary data
Supplementary data are available at BIOLRE online. Figure S1 . Serum P4 levels measured in samples taken via the tail vein from (A) nonpregnant and pregnant CD1 mice on days 14, 16, 17, 18 , and when in labor (n = 6) and from (B) three pregnant CD1 mice administered daily subcutaneous injections of 2 mg progesterone in 40 μl peanut oil vehicle. Samples were taken on E13 (prior commencement of supplementation), E16, E18, and E19/E20. P4 levels were measured using an Abbot Chemiluminescent Microparticle Immunoassay. . Data are expressed as individual data points with median and interquartile range superimposed. Nonpregnant, E16, E17, and E18 cell densities were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when these were not ( * = P < 0.05, * * = P < 0.01 and * * * = P < 0.001, n = 6-13). Figure S6. (A-D) Markers of activation on macrophages in the myometrium of untreated pregnant mice in late gestation. Nonpregnant (myometrium only), E16, E17, and E18. Data are expressed as individual data points with median and interquartile range superimposed. The percentage of macrophages expressing COX-2 and CD86 was compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when these were not. E18 vs. laboring samples were analyzed using an unpaired t-test when normally distributed and a Mann-Whitney test when data were not ( * = P < 0.05 and * * * = P < 0.001, n = 6-14). (ii)K-V: (CCL3, CCL4, CCL11, GM-CSF, IL-2, IL-3, IL-5, IL-9, IL-12p40, IL-12p70, IL-13, IL-17a) levels (pg/ml) measured by multiplex in serum samples obtained from pregnant CD-1 mice on E16, E17, E18, and day of labor. Data are expressed as individual data points with median and interquartile range superimposed and were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not ( * = P < 0.05, * * = P < 0.01 and * * * = P < 0.001, n = 6). Figure S12 . Delivery time after PTL induced by RU486 in vehicle controls and mice given 150 μg of RU486 subcutaneously on the morning of E16. Delivery time was recorded when at least one pup had been delivered. Time to delivery was recorded from the time of RU486 injection. Data are expressed as individual points with median and interquartile range superimposed, and were normally distributed and analyzed using an unpaired t-test ( * * * = P < 0.001, n = 6-7). . One hundred and fifty microgram of RU486 was given subcutaneously on the morning of E16. Eight hours after RU486 administration, mice were either given an oral gavage of 5%DMSO in PBS or 2 mg/kg RS504393 in a maximum volume of 650 μl. Delivery time was recorded when at least one pup had been delivered. Time to delivery was recorded from the time of RU486 injection. Data are expressed as individual points with median and interquartile range superimposed, and were normally distributed and analyzed using an unpaired t-test, n = 6. Supplementary Figure S20. (A-H) Cell numbers and density of leukocytes in the myometrium, placenta, blood, and lungs of mice at the time of RU486-induced parturition treated with either vehicle or the CCR2 antagonist RS504393. Data are expressed as individual points with median and interquartile range superimposed and were analyzed using an unpaired t-test when normally distributed and a Mann-Whitney test when data were not ( * = P < 0.05) n = 6.
Supplementary
Supplementary Figure S21. (A-K) Neutrophil and Ly-6C
HI monocyte cell density in the (A, B) myometrium, (C, D) blood, (E, F) lungs, (G, H) liver (n = 8-10), and (I-K) myometrial macrophage number (I) and markers of activation COX-2 (J) and CD86 (K, n = 3-10) from nonpregnant CD-1 mice given 2 mg of progesterone (P4) in 40 μl peanut oil via a subcutaneous injection daily for 5 days. Cell density (cells/g) was quantified using flow cytometry. Data are expressed as individual data points with median and interquartile range superimposed and were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not ( * = P < 0.05, n = 8-10).
Supplementary Figure S22. (A-H) Neutrophil and Ly-6C
HI monocyte cell density in the (A-D) placenta and (E-H) lungs from pregnant control mice and CD-1 mice given 2 mg progesterone dissolved in 40 μl peanut oil from E14 until E20. Comparative data shown until E19 and then longitudinal data showing progesterone-treated mice at E18-20. Cell density (cells/g) was quantified using flow cytometry. Data are expressed as individual data points with median and interquartile range superimposed. Paired data were analyzed using an unpaired t-test when normally distributed and a Mann-Whitney test when data were not. Longitudinal data were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not ( * = P < 0.05, * * = P < 0.01, * * * = P < 0.001 and * * * * = P < 0.0001, n = 6-10). Figure S23. (A-D) Myometrial (A, C) and placental (B, D) macrophage number from pregnant control mice and CD-1 mice given 2 mg progesterone dissolved in 40 μl peanut oil from E14 until E20, comparative data shown until E19 and then longitudinal data showing progesterone-treated mice at E18-20. Cell density (cells/g) was quantified using flow cytometry. Data are expressed as individual data points with median and interquartile range superimposed. Paired data were analyzed using an unpaired t-test when normally distributed and a Mann-Whitney test when data were not. Longitudinal data were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a KruskalWallis test with a Dunns post test when data were not ( * = P < 0.05 and * * = P < 0.01, n = 6-10).
Supplementary
Supplementary Figure S24. (A-H)
Myometrial cytokine (IL-1α, TNFα, CCL5, and CXCL2) mRNA expression (A-D, housekeeping gene GAPDH) and levels (E-H, pg/ml) measured by quantitative RT-PCR and multiplex respectively. In myometrial samples from pregnant CD-1 mice given 2 mg progesterone dissolved in 40 μl peanut oil from E14 until E20, comparative data shown until E19. Data are expressed as individual data points with median and interquartile range superimposed. Data were analyzed using an unpaired t-test when normally distributed and a Mann-Whitney test when data were not ( * = P < 0.05 and * * = P < 0.01, n = 5-6).
Supplementary Figure S25. (A-F) Myometrial cytokine (IFNγ , GCSF, and IL-10) mRNA expression (A-C, housekeeping gene GAPDH) and levels (D-F, pg/ml) measured by quantitative RT-PCR and multiplex, respectively. In myometrial samples from pregnant CD-1 mice given 2 mg progesterone dissolved in 40 μl peanut oil from E14 until E20, comparative data shown until E19. Data are expressed as individual data points with median and interquartile range superimposed. Data were analyzed using an unpaired t-test when normally distributed and a Mann-Whitney test when data were not ( * = P < 0.05 and * * = P < 0.01, n = 5-6).
Supplementary Figure S26. (A-H)
Myometrial cytokine (IL-1α, TNFα, CCL5, and CXCL2) mRNA expression (A-D, housekeeping gene GAPDH) and levels (E-H, pg/ml) measured by quantitative RT-PCR and multiplex respectively. In myometrial samples from pregnant CD-1 mice given 2 mg progesterone dissolved in 40 μl peanut oil from E14 until E20. Longitudinal data (E18-E20) showing progesterone-treated mice. Data are expressed as individual data points with median and interquartile range superimposed. Longitudinal data were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not ( * = P < 0.05 and * * = P < 0.01, n = 5-6). Figure S27. (A-H) Myometrial cytokine (IFNγ , GCSF, and IL-10) mRNA expression (A-C, housekeeping gene GAPDH) and levels (D-F, pg/ml) measured by quantitative RT-PCR and multiplex respectively. In myometrial samples from pregnant CD-1 mice given 2 mg progesterone dissolved in 40μL peanut oil from E14 until E20. Longitudinal data (E18-E20) showing progesterone-treated mice. Data are expressed as individual data points with median and interquartile range superimposed. Longitudinal data were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not ( * = P < 0.05 and * * = P < 0.01, n = 5-6).
Supplementary
Supplementary Figure S28. (A-D)
Myometrial phospho-ERK1/2 (A, C) and phospho-p65 (B, D) measured by western analysis in myometrial samples obtained from pregnant control mice and CD-1 mice given 2 mg progesterone dissolved in 40 μl peanut oil from E14 until gestational E20. Comparative data shown until E19 and longitudinal data from E18-E20. Data are expressed as individual data points with median and interquartile range superimposed. Paired data were analyzed using an unpaired t-test when normally distributed and a Mann-Whitney test when data were not. Longitudinal data were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not (n = 5-8). Supplementary Figure S29. (A-L) Myometrial cytokine cytokine (IL-1α, IL-1β, IL-6, TNFα, CCL2, CCL5, CXCL1, CXCL2, IL-4, IL-10, G-CSF, and interferon-γ ) levels (pg/ml) measured by multiplex samples obtained from pregnant CD-1 mice on the day of spontaneous labor, RU486-induced labor, and E19 of progesterone (P4) supplementation. Data are expressed as individual data points with median and interquartile range superimposed and were compared using a one-way ANOVA with a Bonferroni post test when normally distributed and a Kruskal-Wallis test with a Dunns post test when data were not ( * = P < 0.05) n = 6. Table S1 . Primer pair sequences, Genebank/EMBL Accession numbers, Nucleotide numbers and Ct values.
